IGHE and asthma: Despite repeated allergen exposure and challenge, Phl p 5+ B cell-treated mice showed a complete lack of allergen-specific IgE and IgG1 responses until week 22, together with effective prevention of mast cell degranulation by week 17 and protection from T cell-mediated asthma by week 39.